Techniques and Outcomes of Taeniamyoectomyised Sigmoid Neobladder in MIS Radical Cystectomy

  • Chunxiao Liu
  • Abai Xu


Several types of bladder replacement have been suggested as intra-abdominal urinary reservoir in patients undergoing radical cystectomy for bladder cancer. An optimal neobladder should maintain continence, metabolic balance, good renal function and quality of life. Ileum is the commonest choice for urologist. But due to its complicated surgical procedures and common postoperative complications, like neobladder dilatation, metabolic problems and infections, there is an urgent need for new generation and improvement of intestinal bladder surgery.

In this article, we introduce our techniques and outcomes of taeniamyoectomyised sigmoid neobladder reconstruction. Our experience showed satisfactory results, and since then orthotopic sigmoid neobladder reconstruction can be one of the choice after radical cystectomy.


Bladder cancer Orthotopic bladder substitute Sigmoid neobladder 



Permission is obtained to show the human images in this article according to local regulation.

Ethical approval is granted for the studies involved in this article according to local regulations.


  1. Abai Xu, Bingkun Li, Hulin Li, Shaobo Zheng, Wei Du, Yawen Xu, Yong Zou, Qiangxiang Luo, and Chunxiao Liu. Comparison of Seromuscular Tunnel and Split-cuff Nipple Antireflux Ureteroenteral Anastomosis Techniques in Orthotopic Taenia Myectomy Sigmoid Neobladder: A Prospective, Randomized Study. Urology. 2013;81(3):669–74.Google Scholar
  2. Alcini E, D’Addessi A, Racioppi M, Menchinelli P, Anastasio G, Grassetti F, Destito A, Giustacchini M. Results of 4 years of experience with bladder replacement using an ileocecal segment with multiple transverse teniamyotomies. J Urol. 1993;149:735–8.CrossRefGoogle Scholar
  3. Anderson CB, Cookson MS, Chang SS. Principles of bladder cancer surgery. In: Castle EP, Pruthi RS, editors. Robotic surgery of the bladder. New York, NY: Springer New York; 2014. p. 5–25.CrossRefGoogle Scholar
  4. Apolo AB, Grossman HB, Bajorin D, Steinberg G, Kamat AM. Practical use of perioperative chemotherapy for muscle-invasive bladder cancer: summary of session at the Society of Urologic Oncology annual meeting. Urol Oncol. 2012;30:772–80.CrossRefGoogle Scholar
  5. Asgari MA, Safarinejad MR, Shakhssalim N, Soleimani M, Shahabi A, Amini E. Quality of life after radical cystectomy for bladder cancer in men with an ileal conduit or continent urinary diversion: a comparative study. Urol Ann. 2013;5:190–6.CrossRefGoogle Scholar
  6. Buzzeo BD, Heisey DM, Messing EM. Bladder cancer in renal transplant recipients. Urology. 1997;50:525–8.CrossRefGoogle Scholar
  7. Chang DT, Lawrentschuk N. Orthotopic neobladder reconstruction. Urol Ann. 2015;7:1–7.CrossRefGoogle Scholar
  8. Egas-Bejar D, Huh WW. Rhabdomyosarcoma in adolescent and young adult patients: current perspectives. Adolesc Health Med Ther. 2014;5:115–25.PubMedPubMedCentralGoogle Scholar
  9. Egbers L, Grotenhuis AJ, Aben KK, Alfred WJ, Kiemeney LA, Vermeulen SH. The prognostic value of family history among patients with urinary bladder cancer. Int J Cancer. 2015;136:1117–24.CrossRefGoogle Scholar
  10. Gupta NP, Kolla SB, Seth A, Dogra PN, Hemal AK, Kumar R, Panda S. Radical cystectomy for bladder cancer: a single center experience. Indian J Urol. 2008;24:54–9.CrossRefGoogle Scholar
  11. Hautmann RE. Clinical scenario: T2 bladder tumor. In: Konety BR, Chang SS, editors. Management of bladder cancer: a comprehensive text with clinical scenarios. New York, NY: Springer New York; 2015. p. 327–36.Google Scholar
  12. Hautmann RE, Volkmer BG, Schumacher MC, Gschwend JE, Studer UE. Long-term results of standard procedures in urology: the ileal neobladder. World J Urol. 2006;24:305–14.CrossRefGoogle Scholar
  13. Hong X, Li T, Ling F, Yang D, Hou L, Li F, Tan W. Impact of surgical margin status on the outcome of bladder cancer treated by radical cystectomy: a meta-analysis. Oncotarget. 2017;8:17258–69.PubMedGoogle Scholar
  14. Jurewicz M, Soloway MS. Approaching the optimal transurethral resection of a bladder tumor. Turk J Urol. 2014;40:73–7.CrossRefGoogle Scholar
  15. Lang H, de Petriconi R, Wenderoth U, Volkmer BG, Hautmann RE, Gschwend JE. Orthotopic ileal neobladder reconstruction in patients with bladder cancer following renal transplantation. J Urol. 2005;173:881–4.CrossRefGoogle Scholar
  16. Lee RK, Abol-Enein H, Artibani W, Bochner B, Dalbagni G, Daneshmand S, Fradet Y, Hautmann RE, Lee CT, Lerner SP, Pycha A, Sievert KD, Stenzl A, Thalmann G, Shariat SF. Urinary diversion after radical cystectomy for bladder cancer: options, patient selection, and outcomes. BJU Int. 2014;113:11–23.CrossRefGoogle Scholar
  17. Liu JM, Cheng SH, Liu XX, Xia C, Wang WW, Ma XL. Prognostic value of caveolin-1 in genitourinary cancer: a meta-analysis. Int J Clin Exp Med. 2015;8:20760–8.PubMedPubMedCentralGoogle Scholar
  18. Malempati S, Hawkins DS. Rhabdomyosarcoma: review of the Children’s Oncology Group (COG) Soft-Tissue Sarcoma Committee experience and rationale for current COG studies. Pediatr Blood Cancer. 2012;59:5–10.CrossRefGoogle Scholar
  19. Manoharan M. Intravesical therapy for urothelial carcinoma of the bladder. Indian J Urol. 2011;27:252–61.CrossRefGoogle Scholar
  20. Medani S, O’Kelly P, O’Brien KM, Mohan P, Magee C, Conlon P. Bladder cancer in renal allograft recipients: risk factors and outcomes. Transplant Proc. 2014;46:3466–73.CrossRefGoogle Scholar
  21. Mirza A, Choudhury A. Bladder preservation for muscle invasive bladder cancer. Bladder Cancer. 2016;2:151–63.CrossRefGoogle Scholar
  22. Moinzadeh A, Gill IS. Laparoscopic radical cystectomy with urinary diversion. Curr Opin Urol. 2004;14(2):83–7.CrossRefGoogle Scholar
  23. Nam JK, Kim TN, Park SW, Lee SD, Chung MK. The Studer orthotopic neobladder: long-term (more than 10 years) functional outcomes, urodynamic features, and complications. Yonsei Med J. 2013;54:690–5.CrossRefGoogle Scholar
  24. Nepple KG, O’Donnell MA. The optimal management of T1 high-grade bladder cancer. Can Urol Assoc J. 2009;3:S188–92.CrossRefGoogle Scholar
  25. Park J, Ahn H. Radical cystectomy and orthotopic bladder substitution using ileum. Korean J Urol. 2011;52:233–40.CrossRefGoogle Scholar
  26. Rama I, Grinyo JM. Malignancy after renal transplantation: the role of immunosuppression. Nat Rev Nephrol. 2010;6:511–9.CrossRefGoogle Scholar
  27. Raney RB, Maurer HM, Anderson JR, Andrassy RJ, Donaldson SS, Qualman SJ, Wharam MD, Wiener ES, Crist WM. The Intergroup Rhabdomyosarcoma Study Group (IRSG): major lessons from the IRS-I through IRS-IV studies as background for the current IRS-V treatment protocols. Sarcoma. 2001;5:9–15.CrossRefGoogle Scholar
  28. Sherwani AY, Wazir BS, Hamid A, Wani MS, Aziz R. Comparative study of various forms of urinary diversion after radical cystectomy in muscle invasive carcinoma urinary bladder. Int J Health Sci (Qassim). 2009;3:3–11.Google Scholar
  29. Stein JP, Lieskovsky G, Ginsberg DA, et al. The T pouch: an orthotopic ileal neobladder incorporating a serosal lined ileal antireflux technique. J Urol. 1998;159(6):1836–42.CrossRefGoogle Scholar
  30. Stein R, Hohenfellner M, Pahernik S, Roth S, Thuroff JW, Rubben H. Urinary diversion—approaches and consequences. Dtsch Arztebl Int. 2012;109:617–22.PubMedPubMedCentralGoogle Scholar
  31. Wu MJ, Lian JD, Yang CR, Cheng CH, Chen CH, Lee WC, Shu KH, Tang MJ. High cumulative incidence of urinary tract transitional cell carcinoma after kidney transplantation in Taiwan. Am J Kidney Dis. 2004;43:1091–7.CrossRefGoogle Scholar
  32. Xu A, Li B, Li H, Zheng S, Du W, Xu Y, Zou Y, Luo Q, Liu C. Comparison of seromuscular tunnel and split-cuff nipple antireflux ureteroenteral anastomosis techniques in orthotopic taenia myectomy sigmoid neobladder: a prospective, randomized study. Urology. 2013a;81(3):669–74.CrossRefGoogle Scholar
  33. Xu K, Liu CX, Zheng SB, Li HL, Xu YW, Xu AB, Chen BS, Shen HY. Orthotopic detaenial sigmoid neobladder after radical cystectomy: technical considerations, complications and functional outcomes. J Urol. 2013b;190:928–34.CrossRefGoogle Scholar
  34. Yang L, Takimoto T, Fujimoto J. Prognostic model for predicting overall survival in children and adolescents with rhabdomyosarcoma. BMC Cancer. 2014;14:654.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  • Chunxiao Liu
    • 1
  • Abai Xu
    • 1
  1. 1.Department of UrologyZhujiang Hospital, Southern Medical University, GuangzhouGuangzhouChina

Personalised recommendations